Bluestar Silicones unveils its new Silbione biomedical liquid silicone rubber product line for long-term implant applications of greater than 30 days in the body at the Medical Design & Manufacturing (MD&M) East Conference (Booth #1030), October 29-30, at the Minneapolis Convention Center. “This introduction marks the first next generation of LSR materials offered to the long-term implant market in decades,” says Karen O’Keefe, marketing director for the company’s U.S. healthcare market. “Bluestar Silicones is excited to bring new performance and processing capabilities to this marketplace. And, we deliver these silicone solutions with a personal touch unmatched in the industry.”
Available in durometer A 01 through 70 hardnesses, this high performance LSR product line offers outstanding physicals to achieve product design optimization in an easy-to-process formulation, improving cycle time and part quality. “Bluestar Silicones continues to invest for aggressive growth in North America and beyond,” says J. Christopher York, president, Bluestar Silicones U.S.A. “Our new manufacturing footprint in York, combined with investments we continue to make in equipment, quality improvements, product development and market expansion, position us for success in our existing and new markets.
We are delivering a functional expertise our customers appreciate and trust. Our goal is to create a unique customer experience that helps our partners excel in their marketplaces.” Bluestar Silicones’ new 226,000 sq. ft. facility in York, SC, which includes state-of-the-art clean rooms and enhanced quality systems, will be the global center of excellence for the company’s implant-grade silicones. With prior experience in long-term implantable applications, Bluestar Silicones offers the broad know-how and unique formulations and master files to support the market’s specific needs. Bluestar Silicones achieved certification under the Responsible Care Management System (RCMS) after three rigorous external audits. This system ensures all processes and procedures are documented, executed and tested on an ongoing basis.